Evidence map›Paper›PMID 17449720›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2007

Biochemical consequences of the NOS3 Glu298Asp variation in human endothelium: altered caveolar localization and impaired response to shear.

Mandar S Joshi, Chieko Mineo, Philip W Shaul, John Anthony Bauer

Open access · greenAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it, 139 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Review
  6. Article
  7. International journal of molecular sciences · 2025
    Article
  8. Frontiers in genetics · 2025
    Article
  9. Article
  10. Review
  11. Article
  12. Single Nucleotide Polymorphisms in Coronary Microvascular Dysfunction.Journal of the American Heart Association · 2024
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Oxidative Stress in Ischemic Heart Disease.Oxidative medicine and cellular longevity · 2020
    Review
  19. Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Mandar S JoshiCenter for Cardiovascular Medicine, Columbus Children's Research Institute, 700 Children's Dr., Columbus, OH 43205, USA.
Chieko Mineo
Philip W Shaul
John Anthony Bauer
Columbus Center · USThe University of Texas Southwestern Medical Center · US

Funding

CHOLESTEROL AND ENDOTHELIAL NO SYNTHASE TRAFFICKINGR01HL058888 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI SHAUL, PHILIP W · 1997 to 2007
$1.9M
COCAINE AND CARDIOVASCULAR DYSFUNCTION IN MURINE AIDSR01HL063067 · NHLBI · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI BAUER, JOHN ANTHONY · 1999 to 2003
$1.2M
UROLOGICAL DYSFUNCTION AND NO CONTROL IN DIABETESR01DK055053 · NIDDK · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI BAUER, JOHN ANTHONY · 1998 to 2002
$554k
NHLBI NIH HHS HL58888NHLBI NIH HHS HL63067NHLBI NIH HHS R01 HL058888NHLBI NIH HHS R01 HL063067NIDDK NIH HHS DK55053NIDDK NIH HHS R01 DK055053
6 · The paper itself

Abstract

Human endothelial nitric oxide synthase (NOS3) gene polymorphism at Exon 7 (Glu298Asp) has been linked to vascular endothelial dysfunction, but the mechanisms are not defined. Shear is a key modulator of NOS3 function in vivo and association with caveolae is important for the control of NOS3 protein activity. Here we tested the hypothesis that altered enrichment of NOS3 in the caveolar membrane defines Glu298Asp genotype-specific responses and NOS3 activity. Basal caveolar membrane enrichment was carried out to quantitate the NOS3 enrichment in caveolae. Cells were subjected to shear and NOS3 protein levels, phosphorylation, enzyme function were investigated. Variant genotypes had lower NOx production pre- and post-shear, but no genotype-dependent alterations in pNOS3 were observed. Asp variants had significantly lower NOS3 enrichment in the caveolar membrane fraction. Further, immunoprecipitation studies demonstrated that Asp variants had substantially less NOS3/Cav-1 association (approximately 40%) during static conditions. Furthermore, acute shear causes impaired NOS3/Cav-1 dissociation in Asp variants. The results from immunoprecipitation studies were in complete agreement with caveolar membrane preparation findings. Collectively, these data demonstrate functional consequences of the Glu298Asp NOS3 variation and further define disruption of NOS3 caveolar localization and shear-induced mobilization as the primary mechanism responsible for these differences.

Indexed as

Polymorphism, Single NucleotideAmino Acid SubstitutionBlotting, WesternCaveolaeCaveolin 1Cells, CulturedEndothelium, VascularGenetic VariationGenotypeHumansImmunoprecipitationNitric OxideNitric Oxide Synthase Type IIIProtein TransportReverse Transcriptase Polymerase Chain ReactionRNA, MessengerCaveolin 1Nitric OxideNitric Oxide Synthase Type IIINOS3 protein, humanRNA, Messenger

Identifiers

PMID17449720
PMCPMC7460804
OpenAlexW2000906636

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.